A Review of Heterogeneity in Attention Deficit/Hyperactivity Disorder (ADHD)

Attention-deficit/hyperactivity disorder (ADHD) is a prevalent neurodevelopmental condition affecting 8%–12% of children worldwide. Despite its high prevalence, the disorder is characterized by significant heterogeneity in its etiology, clinical presentation, and neurobiological underpinnings. No single risk factor is necessary or sufficient to cause ADHD; rather, it arises from a complex interplay of genetic, environmental, and developmental factors. This diversity complicates both diagnosis and the development of curative treatments, as patients often exhibit varied responses to standard pharmacological and behavioral interventions.

ADHD is highly heritable, yet genetic association studies have yielded inconsistent results, likely due to the small individual effect sizes of numerous risk genes. Environmental factors, such as prenatal exposure to toxins or maternal stress, also contribute to risk, often interacting with genetic predispositions. Clinically, ADHD manifests through diverse symptom profiles that evolve across the lifespan, with hyperactive-impulsive behaviors often declining in adulthood while inattentive symptoms may persist. Furthermore, high rates of psychiatric comorbidities—such as anxiety, mood disorders, and learning disabilities—further complicate the clinical picture and treatment outcomes.

Researchers have proposed several theoretical models to explain ADHD, including cognitive-motivational models (focusing on executive function and reward processing), the cognitive-energetic model (focusing on arousal and activation), and neurodevelopmental models (focusing on structural brain maturation). While these models provide valuable insights, they often focus on isolated hypotheses and fail to capture the full spectrum of the disorder's heterogeneity. The authors argue that future research should shift away from broad categorical definitions toward identifying biologically homogeneous subgroups. By focusing on specific clusters—such as familial versus non-familial ADHD or groups defined by specific environmental exposures—researchers may be better positioned to develop personalized, targeted interventions that address the distinct neural anomalies of each subgroup.